FI952797A - D-vitamiinianalogin uusi kiteinen muoto - Google Patents

D-vitamiinianalogin uusi kiteinen muoto Download PDF

Info

Publication number
FI952797A
FI952797A FI952797A FI952797A FI952797A FI 952797 A FI952797 A FI 952797A FI 952797 A FI952797 A FI 952797A FI 952797 A FI952797 A FI 952797A FI 952797 A FI952797 A FI 952797A
Authority
FI
Finland
Prior art keywords
crystalline form
vitamin
analog
new crystalline
calcipotriol
Prior art date
Application number
FI952797A
Other languages
English (en)
Swedish (sv)
Other versions
FI952797A0 (fi
FI108638B (fi
Inventor
Erik Torngaard Hansen
Andersen Niels Smidt Rastrup
Lene Hoffmeyer Ringborg
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10728784&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI952797(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of FI952797A publication Critical patent/FI952797A/fi
Publication of FI952797A0 publication Critical patent/FI952797A0/fi
Application granted granted Critical
Publication of FI108638B publication Critical patent/FI108638B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/02—Apparatus characterised by being constructed of material selected for its chemically-resistant properties
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C5/00—Preparation of hydrocarbons from hydrocarbons containing the same number of carbon atoms
    • C07C5/32—Preparation of hydrocarbons from hydrocarbons containing the same number of carbon atoms by dehydrogenation with formation of free hydrogen
    • C07C5/321—Catalytic processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C5/00—Preparation of hydrocarbons from hydrocarbons containing the same number of carbon atoms
    • C07C5/32—Preparation of hydrocarbons from hydrocarbons containing the same number of carbon atoms by dehydrogenation with formation of free hydrogen
    • C07C5/327—Formation of non-aromatic carbon-to-carbon double bonds only
    • C07C5/333—Catalytic processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C5/00—Preparation of hydrocarbons from hydrocarbons containing the same number of carbon atoms
    • C07C5/32—Preparation of hydrocarbons from hydrocarbons containing the same number of carbon atoms by dehydrogenation with formation of free hydrogen
    • C07C5/327—Formation of non-aromatic carbon-to-carbon double bonds only
    • C07C5/333—Catalytic processes
    • C07C5/3335—Catalytic processes with metals
    • C07C5/3337—Catalytic processes with metals of the platinum group
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/02—Apparatus characterised by their chemically-resistant properties
    • B01J2219/0204—Apparatus characterised by their chemically-resistant properties comprising coatings on the surfaces in direct contact with the reactive components
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/02—Apparatus characterised by their chemically-resistant properties
    • B01J2219/0204—Apparatus characterised by their chemically-resistant properties comprising coatings on the surfaces in direct contact with the reactive components
    • B01J2219/0236—Metal based
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/02—Apparatus characterised by their chemically-resistant properties
    • B01J2219/025—Apparatus characterised by their chemically-resistant properties characterised by the construction materials of the reactor vessel proper
    • B01J2219/0277—Metal based
    • B01J2219/0286—Steel
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2523/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00
    • C07C2523/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00 of noble metals
    • C07C2523/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00 of noble metals of the platinum group metals
    • C07C2523/42—Platinum

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI952797A 1993-01-15 1995-06-07 Menetelmä D-vitamiinianalogin uuden kiteisen muodon valmistamiseksi FI108638B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9300763 1993-01-15
GB939300763A GB9300763D0 (en) 1993-01-15 1993-01-15 Chemical compound
DK9400011 1994-01-07
PCT/DK1994/000011 WO1994015912A1 (en) 1993-01-15 1994-01-07 New crystalline form of a vitamin d analogue

Publications (3)

Publication Number Publication Date
FI952797A true FI952797A (fi) 1995-06-07
FI952797A0 FI952797A0 (fi) 1995-06-07
FI108638B FI108638B (fi) 2002-02-28

Family

ID=10728784

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952797A FI108638B (fi) 1993-01-15 1995-06-07 Menetelmä D-vitamiinianalogin uuden kiteisen muodon valmistamiseksi

Country Status (17)

Country Link
US (2) USRE39706E1 (fi)
EP (1) EP0679154B1 (fi)
JP (1) JP3729847B2 (fi)
KR (1) KR100309751B1 (fi)
CN (1) CN1040746C (fi)
AT (1) ATE159717T1 (fi)
AU (1) AU663249B2 (fi)
CA (1) CA2151730C (fi)
DE (1) DE69406529T2 (fi)
DK (1) DK0679154T3 (fi)
ES (1) ES2111287T3 (fi)
FI (1) FI108638B (fi)
GB (1) GB9300763D0 (fi)
GR (1) GR3025668T3 (fi)
NZ (1) NZ259679A (fi)
RU (1) RU2128646C1 (fi)
WO (1) WO1994015912A1 (fi)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU710931B2 (en) * 1996-02-28 1999-09-30 Sumitomo Pharmaceuticals Company, Limited Crystalline vitamin D derivative
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
HU230045B1 (hu) * 1999-04-23 2015-06-29 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Bőrgyógyászati alkalmazásra szolgáló nem vizes gyógyszerkészítmény
US20090098065A1 (en) * 2000-01-11 2009-04-16 Avikam Harel Composition and methods for the treatment of skin disorders
EP1458678A1 (en) * 2002-11-18 2004-09-22 Teva Pharmaceutical Industries Limited A crystallization method for purification of calcipotriene
US8362287B2 (en) * 2004-03-18 2013-01-29 Leo Pharma A/S Stereoselective synthesis of vitamin D analogues
FR2871696B1 (fr) * 2004-06-17 2006-11-10 Galderma Sa Composition topique pour le traitement du psoriasis
TWI318203B (en) * 2004-09-01 2009-12-11 Leo Pharma As Epimerization of allylic alcohols
EP2526930B1 (en) * 2005-06-01 2013-12-25 GlaxoSmithKline Intellectual Property Development Limited Vitamin formulation
ES2353482T3 (es) * 2006-02-10 2011-03-02 Amgen, Inc Formas hidrato de amg706.
RU2412165C2 (ru) * 2006-03-17 2011-02-20 Лео Фарма А/С Изомеризация фармацевтических интермедиатов
BRPI0715636A2 (pt) * 2006-08-29 2013-07-02 Teva Pharma composiÇÕes farmacologicamente ativas estÁveis incluindo compostos contendo vitamina d e corticosteràide com compatibilidade para ph baixo
WO2008065514A2 (en) * 2006-11-29 2008-06-05 Glenmark Pharmaceuticals Limited Pharmaceutical compositions containing anhydrous calcipotriene
ES2272198B1 (es) * 2006-12-28 2008-06-01 Laboratorios Viñas S.A. Procedimiento para la obtencion de hidrato de calcipotriol.
EP1970048A1 (en) * 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topical composition with vitamin D
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP2008651A1 (en) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited A bioerodible patch
CA2723540C (en) * 2008-05-08 2016-01-05 United Therapeutics Corporation Treprostinil monohydrate
WO2011002756A2 (en) * 2009-07-01 2011-01-06 Vitamin Derivatives, Inc. Vitamin d compounds and methods for preparing same
CN102770125B (zh) 2009-12-22 2015-02-11 利奥制药有限公司 钙泊三醇一水化合物纳米晶体
NZ601002A (en) * 2009-12-22 2014-09-26 Leo Pharma As Pharmaceutical composition comprising vitamin d analogue and cosolvent-surfactant mixture
US9254296B2 (en) 2009-12-22 2016-02-09 Leo Pharma A/S Pharmaceutical composition comprising vitamin D analogue and cosolvent-surfactant mixture
AU2010335654B2 (en) 2009-12-22 2015-04-09 Leo Pharma A/S Cutaneous composition comprising vitamin D analogue and a mixture of solvent and surfactants
BR112012015437A2 (pt) 2009-12-22 2016-03-15 Leo Pharma As composição tópica substancialmente anidra de armazenamento estável
KR101619077B1 (ko) 2010-06-11 2016-05-10 레오 파마 에이/에스 비타민 ｄ 유사체 및 코르티코스테로이드를 포함하는 약제학적 분무 조성물
JP6105494B2 (ja) 2011-03-14 2017-03-29 ドラッグ デリバリー ソリューションズ リミテッド 眼科用組成物
US20140079785A1 (en) 2011-03-24 2014-03-20 Leo Pharma A/S Composition comprising lipid nanoparticles and a corticosteroid or vitamin d derivative
JP5652723B2 (ja) * 2012-08-17 2015-01-14 フォーモサ・ラボラトリーズ・インコーポレーテッド マキサカルシトールの新しい結晶形態
CN103724162A (zh) * 2014-01-07 2014-04-16 成都医路康医学技术服务有限公司 一种银屑病治疗药物卡泊三醇溶剂化物的制备方法
MA41818A (fr) 2015-03-27 2018-01-30 Leo Pharma As Timbre à micro-aiguilles pour administration d'un principe actif à la peau
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2457282A1 (fr) * 1979-05-23 1980-12-19 Roussel Uclaf Nouveau derive du 1a,25 dihydroxy cholecalciferol, son procede de preparation et son application comme medicament
JPS59104358A (ja) 1982-12-03 1984-06-16 Teijin Ltd １α，２４−ジヒドロキシコレカルシフエロ−ルの一水塩及びその製造法
US4866048A (en) * 1985-08-02 1989-09-12 Leo Pharmaceutical Products Ltd. Novel vitamin D analogues
GB9004544D0 (en) * 1990-03-01 1990-04-25 Leo Pharm Prod Ltd Novel treatment ii

Also Published As

Publication number Publication date
US5763426A (en) 1998-06-09
AU5857394A (en) 1994-08-15
ATE159717T1 (de) 1997-11-15
CA2151730C (en) 2005-01-04
USRE39706E1 (en) 2007-06-26
DK0679154T3 (da) 1998-03-30
FI952797A0 (fi) 1995-06-07
RU95116650A (ru) 1997-06-10
CN1115979A (zh) 1996-01-31
GR3025668T3 (en) 1998-03-31
JPH08505612A (ja) 1996-06-18
JP3729847B2 (ja) 2005-12-21
EP0679154A1 (en) 1995-11-02
KR100309751B1 (ko) 2002-11-08
DE69406529D1 (de) 1997-12-04
KR950704249A (ko) 1995-11-17
CA2151730A1 (en) 1994-07-21
CN1040746C (zh) 1998-11-18
EP0679154B1 (en) 1997-10-29
RU2128646C1 (ru) 1999-04-10
AU663249B2 (en) 1995-09-28
FI108638B (fi) 2002-02-28
ES2111287T3 (es) 1998-03-01
GB9300763D0 (en) 1993-03-03
WO1994015912A1 (en) 1994-07-21
DE69406529T2 (de) 1998-05-28
NZ259679A (en) 1996-11-26

Similar Documents

Publication Publication Date Title
FI952797A0 (fi) D-vitamiinianalogin uusi kiteinen muoto
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
MY104685A (en) Substituted thiazoles and their use as fungicides.
AU2524692A (en) Novel 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace
TW225534B (fi)
NO944430L (no) 4-mercaptoacetylamino-[2Åbenzazepinon(3)-derivater, og anvendelse som enkefalinaseinhibitorer
ZA9710796B (en) Oxyiminopregnanecarbolactones.
DE69230180D1 (de) Neuartige hefestämme zur herstellung von xylitol
FI935110A (fi) N,N-disubstituerade arylcykloalkylaminer, deras salter, dessa foereningar innehaollande laekemedel och deras anvaendning samt foerfarande foer deras framstaellning
MX9302116A (es) Compuestos azabiciclo.
HU9601646D0 (en) 4-benzoylisoxazoles and their use as herbicides
DE69333302D1 (de) Mikroorganismen, ihre herstellung und verwendung
ES2118248T3 (es) Esteres y amidas de 9-cloro-prostaglandina y su empleo para preparar medicamentos.
BR9606955A (pt) Heterocicloalquenos substituísos
DE69418938D1 (de) Zusatzmittel zur herstellung von legierungen
FI934468A0 (fi) Bensenborsyraderivat, foerfarande foer deras framstaellning och deras anvaendning som sytesmellanprodukter
BR9300855A (pt) Composicao,estrutura cimentosa,metodo para melhorar a estabilidade de uma estrutura cimentosa,e metodo para obter uma estrutura cimentosa
ATE204286T1 (de) Modifizierte alpha-d-glcp-(1,2)-alpha-d-glcp-(1, 3)-alpha-d-glcp-analoge
AU1516892A (en) Novel 2-mercaptomethylene-tetrahydronaphthalene and indane-2-carboxamide derivatives as enkephalinase inhibitors
CA2183314A1 (en) Novel 2-Substituted Indane-2-Mercaptoacetylamide Disulfide Derivatives Useful as Inhibitors of Enkephalinase and Ace
ES2065842A1 (es) Aplicacion de ent-3b,6b,12b-trihidroxi-13-epi-oxido de manoilo como activador de la adenilatociclasa.
ES2065844A1 (es) Aplicacion de ent-16,18-dihidroxi-6-oxo-oxido de manoilo como inhibidor de la adenilatociclasa.
ES2065843A1 (es) Aplicacion de ent-11 , 16-dihidroxi-18-nor-4a -carboximetil-oxido de manoilo como inhibidor de la adenilatociclasa.
GR1001393B (el) Παράγωγα ιμιδαζο[2,1-Β] 3] βενζαζεπίνης, συν?έσεις και μέ?οδος χρήσεως.

Legal Events

Date Code Title Description
MA Patent expired